中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 10
Oct.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(10): 2405-2407

Hepatitis E virus infection after liver transplantation: A case report

DOI: 10.3969/j.issn.1001-5256.2021.10.029
  • 1.

    Department of Organ Transplantation, The Third Medical Center of Chinese PLA General Hospital, Beijing 100089, China

  • 2.

    Department of Liver Transplantation, Beijing Tsinghua Changgung Hospital, Beijing 100089, China

  • 3.

    Department of Gastroenterology, Tianjin People's Hospital, Tianjin 300000, China

  • Received Date: 2021-03-03
  • Accepted Date: 2021-06-17
  • Published Date: 2021-10-20
    Abstract
    • FullText(HTML)
  • loading
    • References(19)
  • [1]
    KAMAR N, BENDALL R, LEGRAND-ABRAVANEL F, et al. Hepatitis E[J]. Lancet, 2012, 379(9835): 2477-2488. DOI: 10.1016/S0140-6736(11)61849-7.
    [2]
    ANKCORN MJ, TEDDER RS. Hepatitis E: The current state of play[J]. Transfus Med, 2017, 27(2): 84-95. DOI: 10.1111/tme.12405.
    [3]
    HAAGSMA EB, van den BERG AP, PORTE RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients[J]. Liver Transpl, 2008, 14(4): 547-553. DOI: 10.1002/lt.21480.
    [4]
    COLSON P, KABA M, MOREAU J, et al. Hepatitis E in an HIV-infected patient[J]. J Clin Virol, 2009, 45(4): 269-271. DOI: 10.1016/j.jcv.2009.06.002.
    [5]
    DALTON HR, BENDALL RP, KEANE FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection[J]. N Engl J Med, 2009, 361(10): 1025-1027. DOI: 10.1056/NEJMc0903778.
    [6]
    PISCHKE S, SUNEETHA PV, BAECHLEIN C, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients[J]. Liver Transpl, 2010, 16(1): 74-82. DOI: 10.1002/lt.21958.
    [7]
    HAAGSMA EB, NIESTERS HG, van den BERG AP, et al. Prevalence of hepatitis E virus infection in liver transplant recipients[J]. Liver Transpl, 2009, 15(10): 1225-1228. DOI: 10.1002/lt.21819.
    [8]
    HOERNING A, HEGEN B, WINGEN AM, et al. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients-a single-center experience[J]. Pediatr Transplant, 2012, 16(7): 742-747. DOI: 10.1111/j.1399-3046.2012.01740.x.
    [9]
    LEGRAND-ABRAVANEL F, KAMAR N, SANDRES-SAUNE K, et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France[J]. Emerg Infect Dis, 2011, 17(1): 30-37. DOI: 10.3201/eid1701.100527.
    [10]
    PAS SD, de MAN RA, MULDERS C, et al. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands[J]. Emerg Infect Dis, 2012, 18(5): 869-872. DOI: 10.3201/eid1805.111712.
    [11]
    KAMAR N, GARROUSTE C, HAAGSMA EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organtransplants[J]. Gastroenterology, 2011, 140(5): 1481-1489. DOI: 10.1053/j.gastro.2011.02.050.
    [12]
    KAMAR N, SELVES J, MANSUY JM, et al. Hepatitis E virus and chronic hepatitis inorgan-transplant recipients[J]. N Engl J Med, 2008, 358(8): 811-817. DOI: 10.1056/NEJMoa0706992.
    [13]
    AGGARWAL R. Hepatitis E: Does it cause chronic hepatitis E[J]. Hepatology, 2008, 48(4): 1328-1330. DOI: 10.1002 /hep.22548.
    [14]
    KAMAR N, WECLAWIAK H, GUILBEAU-FRUGIER C, et al. Hepatitis E virus and the kidney in solid-organ transplant patients[J]. Transplantation, 2012, 93(6): 617-23. DOI: 10.1097/TP.0b013e318245f14c.
    [15]
    DEL BELLO A, ARNE-BES MC, LAVAYSSIERE L, et al. Hepatitis E virus-induced severe myositis[J]. J Hepatol, 2012, 57(5): 1152-1153. DOI: 10.1016/j.jhep.2012.05.010.
    [16]
    TATON B, MOREAU K, LEPREUX S, et al. Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation[J]. Transpl Infect Dis, 2013, 15(6): e211-e215. DOI: 10.1111/tid.12143.
    [17]
    AGGARWAL A, PERUMPAIL RB, TUMMALA S, et al. Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management[J]. World J Hepatol, 2016, 8(2): 117-122. DOI: 10.4254/wjh.v8.i2.117.
    [18]
    ZHU FC, ZHANG J, ZHANG XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: A large-scale, randomised, double-blind placebo-controlled, phase 3 trial[J]. Lancet, 2010, 376(9744): 895-902. DOI: 10.1016/S0140-6736(10)61030-6.
    [19]
    ZHANG LX, WANG YY, CHEN YQ, et al. Review of infectious diseases in 2012[J]. Infect Dis Info, 2013, 26(1): 10-16. DOI: 10.3969/j.issn.1007-8134.2013.01.002.

    张玲霞, 王永怡, 陈玉琪, 等. 2012年传染病热点回顾[J]. 传染病信息, 2013, 26(1): 10-16. DOI: 10.3969/j.issn.1007-8134.2013.01.002.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (372) PDF downloads(39) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return